{"changes":[{"companyHref":"/c/vstbio-com","date":"2026-09-25","documentUrl":null,"domain":"vstbio.com","fact":"latest round","name":"VST BIO Corp","new":{"amountUsd":31888146,"date":"2026-04-24","lead":null,"type":null},"old":{"amountUsd":31888146,"date":"2026-04-24","lead":null,"type":"seed"},"publisher":"sec-edgar","reason":null,"retrievedAt":"2026-05-08","slug":"vstbio-com","status":"attributed","url":"https://whoraisedwhat.com/c/vstbio-com"}],"country":"US","description":"VST Bio is a biotechnology company developing therapeutics aimed at modulating the immune system to treat inflammatory and immune-related disease. It is oriented toward patients and clinical partners in immunology and inflammation. Its work centers on a targeted mechanism for immune dysregulation that broad drugs do not selectively reach.","domain":"vstbio.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":32.71742,"lng":-117.162772,"location":"SAN DIEGO, CA","name":"VST BIO Corp","rounds":[{"amountQuarantined":false,"amountUsd":31888146,"currency":"USD","date":"2026-04-24","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":null,"url":null}],"slug":"vstbio-com","sources":[{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"vstbio.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://vstbio.com"},{"fact":"description","publisher":"vstbio.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://vstbio.com"}],"stage":null,"techStack":[],"totalRaisedUsd":31888146,"updatedAt":"2026-05-08"}